Market revenue in 2024 | USD 5,151.9 million |
Market revenue in 2030 | USD 7,719.3 million |
Growth rate | 7% (CAGR from 2025 to 2030) |
Largest segment | Glucose oxidase/glucose dehydrogenase |
Fastest growing segment | Lactate dehydrogenase |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Taq polymerase, MMLV RT, HIV RT, Hot start Taq pol, UNG, RNase inhibitor, Bst polymerase (LAMP enzyme), PCR Master Mix, Lyophilised Polymerase, T7 RNA polymerase, Cas9 enzyme, Acid phosphatase, Alanine aminotransferase, Alkaline phosphatase, Amylase, Angiotensin converting enzyme, Aspartate aminotransferase, Cholinesterase, Creatinine kinase, Gamma glutamyl transferase, Lactate dehydrogenase, Renin, Glucose oxidase/glucose dehydrogenase, Urease, Lactate oxidase, Horseradish peroxidase, Glutamate oxidase |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diagnostic enzymes market will help companies and investors design strategic landscapes.
Glucose oxidase/glucose dehydrogenase was the largest segment with a revenue share of 9.31% in 2024. Horizon Databook has segmented the Global diagnostic enzymes market based on taq polymerase, mmlv rt, hiv rt, hot start taq pol, ung, rnase inhibitor, bst polymerase (lamp enzyme), pcr master mix, lyophilised polymerase, t7 rna polymerase, cas9 enzyme, acid phosphatase, alanine aminotransferase, alkaline phosphatase, amylase, angiotensin converting enzyme, aspartate aminotransferase, cholinesterase, creatinine kinase, gamma glutamyl transferase, lactate dehydrogenase, renin, glucose oxidase/glucose dehydrogenase, urease, lactate oxidase, horseradish peroxidase, glutamate oxidase covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of global-level data and insights on the Global diagnostic enzymes market , including forecasts for subscribers. This global databook contains high-level insights into Global diagnostic enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Type | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
North America | 1,654.4 | 1,710.2 | 2,577.9 | 2,189.6 | 2,034.2 | 2,144.4 | 2,265.7 | 2,399.4 | 2,546.8 | 2,709.3 | 2,888.7 | 3,086.9 | 3,306.1 | 6.5% |
Europe | 972.6 | 1,011.6 | 1,534.4 | 1,311.6 | 1,226.3 | 1,301.0 | 1,383.6 | 1,474.9 | 1,575.9 | 1,687.7 | 1,811.6 | 1,949.2 | 2,102.1 | 7.2% |
Asia Pacific | 764.3 | 800.4 | 1,222.3 | 1,052.1 | 990.5 | 1,058.3 | 1,133.5 | 1,217.0 | 1,309.7 | 1,413.0 | 1,528.0 | 1,656.3 | 1,799.7 | 8.0% |
Latin America | 158.0 | 162.4 | 243.4 | 205.5 | 189.9 | 199.0 | 209.0 | 220.0 | 232.1 | 245.4 | 260.0 | 276.1 | 293.9 | 5.9% |
MEA | 124.9 | 127.8 | 190.5 | 160.0 | 147.0 | 153.2 | 160.1 | 167.6 | 175.8 | 184.8 | 194.8 | 205.7 | 217.6 | 5.3% |
Overall | 3,674.3 | 3,812.4 | 5,768.5 | 4,918.8 | 4,587.8 | 4,856.0 | 5,151.9 | 5,478.8 | 5,840.2 | 6,240.1 | 6,683.1 | 7,174.2 | 7,719.3 | 7.0% |
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account